Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Date: October 26, 2020
Reporting Period: Current announcement date (Non-financial period report)
Context: CCEP, the world's largest Coke bottler by revenue serving over 300 million consumers in Western Europe, announced a non-binding proposal to acquire Coca-Cola Amatil Limited (CCL), a major bottler in the Asia Pacific region.
Key Financial Metrics and Transaction Valuation
Transaction Valuation (CCL):
- Equity Value: Approximately A$8.7 billion (c. €5.2 billion) on a fully diluted basis.
- Enterprise Value (EV): Approximately A$10.8 billion (c. €6.5 billion).
- Valuation Multiple: 10.9x EV/EBITDA based on CCL's FY19 reported underlying EBITDA.
- Independent Shareholders: A$12.75 per share in cash (23% premium to 1-week VWAP, 38% premium to 3-month VWAP).
- The Coca-Cola Company (KO): A$9.57 per share in cash for 10.8% of shares; remaining 20% interest to be acquired via cash and/or CCEP shares.
- Revenue: A$5.1 billion (c. €3.1 billion).
- EBITDA: A$1.0 billion (c. €0.6 billion).
- Geographic Split: Approximately 75% of revenue generated from Australia and New Zealand.
Note: This filing does not provide CCEP's current revenue, profit, cash flow, debt, or liquidity metrics for the period ending October 26, 2020.
Material Changes and Strategic Rationale
The primary material change is the proposed acquisition of CCL, which represents a significant strategic shift for CCEP:
- Geographic Diversification: Expands CCEP's footprint from Western Europe into the Asia Pacific region.
- Consumer Reach: Aims to almost double CCEP's consumer reach.
- Scale: Intended to drive sustainable and faster growth through increased scale.
- Balance Sheet Impact: The transaction implies a significant increase in enterprise value and potential leverage, though specific debt financing terms are not detailed in this non-binding proposal.
Guidance, Outlook, Risks, and Contingencies
Outlook and Conditions:
The proposal is non-binding and subject to several contingencies, including satisfactory confirmatory due diligence, negotiation of a scheme implementation deed, Australian regulatory approvals, and shareholder approval. There is no certainty that a binding transaction will occur.
Key Risks and Contingencies:
- Transaction Risks: Failure to integrate successfully, inability to raise financing, failure to obtain regulatory approvals, or unexpected liabilities.
- Operational Risks: Disruption of ongoing business, diversion of management attention, and potential loss of key employees.
- Market Risks: Negative market reaction if the acquisition is delayed or fails; potential litigation.
- Macro Risks: Impact of the COVID-19 pandemic on financial results, operations, and demand; UK exit from the EU; changing consumer preferences (e.g., sugar alternatives); and climate change regulations.
Management Commentary:
Management views the transaction as creating a broader, more balanced footprint to drive growth. An investor and analyst conference call was held to discuss the announcement.
Important Facts for Investor Verification
- Binding Status: Verify if a binding Scheme Implementation Deed has been signed, as the current proposal is non-binding.
- Financing Structure: Confirm the final mix of cash and equity used to acquire KO's remaining 20% stake and the total debt financing required.
- Regulatory Approval: Monitor the status of Australian regulatory approvals, which are a condition precedent.
- Due Diligence: Await the completion of confirmatory due diligence to ensure no material adverse findings.
- Shareholder Recommendation: Confirm the final recommendation of the CCL Board (excluding KO nominees) and the independent expert's opinion on the fairness of the scheme.